Bibliographic information
Guideline—
Year of Publication—
Issuing Institution—
Recommendation
New
Artemisinin-based combination therapies should be used in preference to sulfadoxinepyrimethamine (SP) plus amodiaquine (AQ) for the treatment of uncomplicated P. falciparum malaria.
Recommended in favor
Strong
Certainty of evidence
Moderate
Notes and Remarks
Addition of a single dose primaquine (0.75 mg/kg) to ACT treatment for uncomplicated falciparum malaria as an antigametocyte medicine, particularly as a component of pre-elimination or an elimination programme.